{"entity":{"type":"insider","cik":"0001708172","url":"/insider/0001708172","json_url":"/insider/0001708172.json","name":"KASINGER JAMES R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":12,"first":"2021-01-20","last":"2026-03-24","span_basis":"filed_date"},"name_variants":[{"name":"KASINGER JAMES R.","source":"filing","n_filings":12,"first_seen":"2021-01-20","last_seen":"2026-03-24"}],"transactions":[{"id":5979311,"accession":"0001193125-26-122274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-122274","line_url":"/filing/0001193125-26-122274#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3182.0,"shares_display":"3,182","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":148853.96,"total_display":"148,853.96","total_whole":"148,854","shares_owned_after":94308.0,"shares_owned_after_display":"94,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":6134360,"accession":"0001193125-26-111281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-111281","line_url":"/filing/0001193125-26-111281#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3450.0,"shares_display":"3,450","price_per_share":48.26,"price_display":"48.26","price_state":"stated","total_value":166497.0,"total_display":"166,497.00","total_whole":"166,497","shares_owned_after":91240.0,"shares_owned_after_display":"91,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":6073061,"accession":"0001193125-26-104481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-104481","line_url":"/filing/0001193125-26-104481#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":147840.0,"total_display":"147,840.00","total_whole":"147,840","shares_owned_after":87815.0,"shares_owned_after_display":"87,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-12","scope":"insider"},{"id":5904652,"accession":"0001193125-26-061710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-061710","line_url":"/filing/0001193125-26-061710#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2112.0,"shares_display":"2,112","price_per_share":52.58,"price_display":"52.58","price_state":"stated","total_value":111048.96,"total_display":"111,048.96","total_whole":"111,049","shares_owned_after":85115.0,"shares_owned_after_display":"85,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-19","filed_date":"2026-02-20","scope":"insider"},{"id":4171262,"accession":"0001193125-25-240437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-240437","line_url":"/filing/0001193125-25-240437#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1076.0,"shares_display":"1,076","price_per_share":66.6,"price_display":"66.60","price_state":"stated","total_value":71661.6,"total_display":"71,661.60","total_whole":"71,662","shares_owned_after":83402.0,"shares_owned_after_display":"83,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-14","filed_date":"2025-10-15","scope":"insider"},{"id":4525967,"accession":"0000950170-25-043972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043972","line_url":"/filing/0000950170-25-043972#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3185.0,"shares_display":"3,185","price_per_share":41.23,"price_display":"41.23","price_state":"stated","total_value":131317.55,"total_display":"131,317.55","total_whole":"131,318","shares_owned_after":81729.0,"shares_owned_after_display":"81,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":4417022,"accession":"0000950170-25-038215","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-038215","line_url":"/filing/0000950170-25-038215#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1116.0,"shares_display":"1,116","price_per_share":43.32,"price_display":"43.32","price_state":"stated","total_value":48345.12,"total_display":"48,345.12","total_whole":"48,345","shares_owned_after":78664.0,"shares_owned_after_display":"78,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":4417017,"accession":"0000950170-25-038215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-038215","line_url":"/filing/0000950170-25-038215#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":42.42,"price_display":"42.42","price_state":"stated","total_value":120897.0,"total_display":"120,897.00","total_whole":"120,897","shares_owned_after":77530.0,"shares_owned_after_display":"77,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4059264,"accession":"0000950170-25-023386","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-023386","line_url":"/filing/0000950170-25-023386#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1947.0,"shares_display":"1,947","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":102801.6,"total_display":"102,801.60","total_whole":"102,802","shares_owned_after":74880.0,"shares_owned_after_display":"74,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4059262,"accession":"0000950170-25-023386","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-023386","line_url":"/filing/0000950170-25-023386#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9595.0,"shares_display":"9,595","price_per_share":53.85,"price_display":"53.85","price_state":"stated","total_value":516690.75,"total_display":"516,690.75","total_whole":"516,691","shares_owned_after":73002.0,"shares_owned_after_display":"73,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":2142978,"accession":"0000950170-24-114787","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-114787","line_url":"/filing/0000950170-24-114787#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":46.28,"price_display":"46.28","price_state":"stated","total_value":50398.92,"total_display":"50,398.92","total_whole":"50,399","shares_owned_after":62597.0,"shares_owned_after_display":"62,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-14","filed_date":"2024-10-15","scope":"insider"},{"id":2066848,"accession":"0000950170-24-030190","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-030190","line_url":"/filing/0000950170-24-030190#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1146.0,"shares_display":"1,146","price_per_share":74.44,"price_display":"74.44","price_state":"stated","total_value":85308.24,"total_display":"85,308.24","total_whole":"85,308","shares_owned_after":61174.0,"shares_owned_after_display":"61,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2066847,"accession":"0000950170-24-030190","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-030190","line_url":"/filing/0000950170-24-030190#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2801.0,"shares_display":"2,801","price_per_share":78.26,"price_display":"78.26","price_state":"stated","total_value":219206.26,"total_display":"219,206.26","total_whole":"219,206","shares_owned_after":60070.0,"shares_owned_after_display":"60,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2892934,"accession":"0000950170-24-018175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-018175","line_url":"/filing/0000950170-24-018175#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1913.0,"shares_display":"1,913","price_per_share":79.67,"price_display":"79.67","price_state":"stated","total_value":152408.71,"total_display":"152,408.71","total_whole":"152,409","shares_owned_after":57371.0,"shares_owned_after_display":"57,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":4221587,"accession":"0001209191-21-004452","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-004452","line_url":"/filing/0001209191-21-004452","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001708172","owner_name":"KASINGER JAMES R.","owner_display_name":"KASINGER JAMES R.","owner_url":"/insider/0001708172","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27500.0,"shares_display":"27,500","price_per_share":204.94340727272728,"price_display":"204.94","price_state":"stated","total_value":5635943.7,"total_display":"5,635,943.70","total_whole":"5,635,944","shares_owned_after":26331.0,"shares_owned_after_display":"26,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-20","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (General Counsel and Secretary)","n_filings":12,"first_seen":"2021-01-20","last_seen":"2026-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001708172","retrieved_at":"2026-08-23T05:27:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}